Andrea Martinez-Cuartero

Santiago De Compostela, GA 15706, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Systemic Immune and miRNA Signatures Associated with Long-Term Ranibizumab Response in Neovascular Age-Related Macular Degeneration.

Systemic Immune and miRNA Signatures Associated with Long-Term Ranibizumab Response in Neovascular Age-Related Macular Degeneration.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: May 07, 2026

Prolonged linezolid therapy induces progressive mitochondrial dysfunction in human peripheral blood mononuclear cells.

Prolonged linezolid therapy induces progressive mitochondrial dysfunction in human peripheral blood mononuclear cells.

Journal: Journal of translational medicine

Published: March 05, 2026

Intravitreal faricimab pharmacokinetics assessed by PET imaging in a neovascular Age-related Macular Degeneration rat model.

Intravitreal faricimab pharmacokinetics assessed by PET imaging in a neovascular Age-related Macular Degeneration rat model.

Journal: International journal of pharmaceutics: X

Published: March 03, 2026

A systematic review on age-related macular degeneration: New insights from multi-omics studies.

A systematic review on age-related macular degeneration: New insights from multi-omics studies.

Journal: Survey of ophthalmology

Published: November 10, 2025

Long-term clinical outcomes of 0.015 % tacrolimus HPβCD eye drops in ocular surface inflammatory disorders.

Long-term clinical outcomes of 0.015 % tacrolimus HPβCD eye drops in ocular surface inflammatory disorders.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Published: November 05, 2025

Design and characterization of intravitreal bevacizumab-loaded PLGA nanoparticles: pharmacokinetic and biodistribution impact.

Design and characterization of intravitreal bevacizumab-loaded PLGA nanoparticles: pharmacokinetic and biodistribution impact.

Journal: Drug delivery and translational research

Published: May 24, 2025

Clinical Effectiveness, Safety, and Compliance of Two Compounded Formulations of Tacrolimus Eye Drops: An Open-Label, Sequential Prospective Study.

Clinical Effectiveness, Safety, and Compliance of Two Compounded Formulations of Tacrolimus Eye Drops: An Open-Label, Sequential Prospective Study.

Journal: International journal of molecular sciences

Published: August 02, 2024

Preclinical characterization of endotoxin-induced uveitis models using OCT, PET/CT and proteomics.

Preclinical characterization of endotoxin-induced uveitis models using OCT, PET/CT and proteomics.

Journal: International journal of pharmaceutics

Published: May 16, 2024

Cysteamine Eye Drops in Hyaluronic Acid Packaged in Innovative Single-Dose Systems, Part II: Long-Term Stability and Clinical Ocular Biopermanence.

Cysteamine Eye Drops in Hyaluronic Acid Packaged in Innovative Single-Dose Systems, Part II: Long-Term Stability and Clinical Ocular Biopermanence.

Journal: Pharmaceutics

Published: September 27, 2023

Stability of insulin eye drops in the treatment of refractory corneal ulcers.

Stability of insulin eye drops in the treatment of refractory corneal ulcers.

Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria

Published: December 15, 2022

Cysteamine Eye Drops in Hyaluronic Acid Packaged in Innovative Single-Dose Systems: Stability and Ocular Biopermanence.

Cysteamine Eye Drops in Hyaluronic Acid Packaged in Innovative Single-Dose Systems: Stability and Ocular Biopermanence.

Journal: Pharmaceutics

Published: September 23, 2022

Showing 1-11 of 11

Last Updated: 09/26/2026